- Home
- CELC vs DHT Comparison
CELC vs DHT Comparison
Compare CELC & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELC | DHT |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2017 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CELC | DHT |
|---|---|---|
| Price | $120.90 | $18.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $112.56 | $19.33 |
| AVG Volume (30 Days) | 649.3K | ★ 3.4M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.85 |
| Revenue Next Year | $720.19 | N/A |
| P/E Ratio | ★ N/A | $12.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.64 | $10.50 |
| 52 Week High | $129.09 | $20.55 |
Technical Indicators
Market Signals| Indicator | CELC | DHT |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 55.35 |
| Support Level | $99.38 | $16.88 |
| Resistance Level | N/A | $18.80 |
| Average True Range (ATR) | 7.46 | 0.70 |
| MACD | -0.18 | 0.01 |
| Stochastic Oscillator | 63.82 | 68.09 |
Price Performance
Historical ComparisonAbout CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.